Adrian Dubock, Ph.D.
Dr. Dubock is a member of the Advisory Board of the Freiburg Institute of Advanced Studies, School of Life Sciences and School of Soft Matter Research, Albert-Ludwigs-Universität, Freiburg, Germany. Formerly a senior executive of Syngenta responsible for Mergers, Acquisitions, Ventures and Intellectual Property Licensing, he is currently the Executive Secretary of the Golden Rice Humanitarian Board, and also Golden Rice Project Manager.
Dr. Dubock reports no commercial conflicts of interest.
Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Describe how a genetically modified crop differs from a conventionally bred crop
- Describe the benefits of biofortification compared to fortification or supplementation as exemplified by Golden Rice
- Discuss the scientific evidence for more or less caution with respect to genetically modified crops.